Axent Bio is honored to participate in ISSCR’s 20th Anniversary iPSC Symposium in Kyoto, celebrating two decades of innovation in stem cell science and exploring the future of regenerative medicine.

Axent Bio will join the global stem cell community at the ISSCR 2026 Annual Meeting in Montréal to share advances in scalable manufacturing and clinical translation of cell therapies.

Axent Bio Welcomes Dana Wilkins to the team as 2026 QWEST Intern working in the Analytical Development Team

Axent Bio welcomes Sungmin Kim to the team as a Research Associate working in the Process Development Team

Axent Bio is thrilled to participate in the 2025 ISSCR International Symposium in Boston, engaging with researchers and industry partners working to advance stem cell technologies from discovery to therapeutic impact.

Axent Bio will attend Meeting on the Mesa 2025 to connect with investors, biotech leaders, and innovators advancing the commercialization of regenerative medicine and cell therapy technologies.

Axent Bio Welcomes Aria Kumar to the team as a Research Associate working in the Analytical Development Team

Axent Bio Welcomes Samantha Smith and Sungmin Kim to the team as 2025 QWEST Interns working in the Analytical Development and Process Development Teams

We’re excited to announce that Axent Bio has been awarded a Translational Award from the California Institute for Regenerative Medicine (CIRM) to advance our scalable cell therapy platform for Parkinson’s disease.

In a recent interview with Alejandro Cremades, Axent Bio co-founder David Schaffer shared his journey from academic scientist to serial biotech entrepreneur.